Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q5XFR0

Entry ID Method Resolution Chain Position Source
AF-Q5XFR0-F1 Predicted AlphaFoldDB

29 variants for Q5XFR0

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389014710 9 L>V No EVA
rs236908482 34 G>S No EVA
rs264790772 37 E>K No EVA
rs248907333 45 A>V No EVA
rs3388967158 54 E>K No EVA
rs259824009 79 F>Y No EVA
rs3399717448 83 L>F No EVA
rs3389014742 94 E>Q No EVA
rs3389022826 98 A>V No EVA
rs1133448735 102 P>T No EVA
rs3388986293 103 P>S No EVA
rs1134807238 105 V>I No EVA
rs1134224468 108 K>R No EVA
rs33110169 113 E>K No EVA
rs3413072071 119 Q>R No EVA
rs3389020557 177 D>G No EVA
rs3389010841 180 S>Y No EVA
rs3389022789 194 H>Q No EVA
rs3389016116 195 R>T No EVA
rs3389016687 208 F>I No EVA
rs3389014743 211 R>W No EVA
rs3388992336 213 I>F No EVA
rs3388992336 213 I>V No EVA
rs3389016110 225 I>N No EVA
rs3389016693 226 S>I No EVA
rs33250225 239 N>S No EVA
rs3389010859 245 H>Y No EVA
rs254301586 264 G>R No EVA
rs3388998078 266 A>S No EVA

No associated diseases with Q5XFR0

1 regional properties for Q5XFR0

Type Name Position InterPro Accession
domain RNA recognition motif domain 143 - 220 IPR000504

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

2 GO annotations of molecular function

Name Definition
poly(A) binding Binding to a sequence of adenylyl residues in an RNA molecule, such as the poly(A) tail, a sequence of adenylyl residues at the 3' end of eukaryotic mRNA.
RNA binding Binding to an RNA molecule or a portion thereof.

5 GO annotations of biological process

Name Definition
maternal-to-zygotic transition of gene expression Any process that modulates the frequency, rate or extent of gene expression by which developmental control passes from the maternal genome to the zygotic genome.
negative regulation of protein binding Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.
negative regulation of protein ubiquitination Any process that stops, prevents, or reduces the frequency, rate or extent of the addition of ubiquitin groups to a protein.
negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process Any process that stops or decreases the rate, frequency or extent of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process, the chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, with ubiquitin-protein ligation catalyzed by an SCF (Skp1/Cul1/F-box protein) complex, and mediated by the proteasome.
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay A major pathway of degradation of nuclear-transcribed mRNAs that proceeds through a series of ordered steps that includes poly(A) tail shortening and that can regulate mRNA stability.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q28165 PABPN1 Polyadenylate-binding protein 2 Bos taurus (Bovine) PR
Q86U42 PABPN1 Polyadenylate-binding protein 2 Homo sapiens (Human) PR
Q8CCS6 Pabpn1 Polyadenylate-binding protein 2 Mus musculus (Mouse) PR
B0BNE4 Pabpn1l Embryonic polyadenylate-binding protein 2 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MEPYLSNELF PPPTEAWLQT VSSDPEAQGW GAWGRTEKTS LVPRAGSRAG SDKEAEENED
70 80 90 100 110 120
ASFLLSLLEP ENLAKSPVFN QELEAIKLKL WAMEHAEAQP EPPCVQRKAT EEERAEVRQL
130 140 150 160 170 180
LSPETVDCFF SRTSKENVEA DHRSVFVGNV DYGGSAAELE AYFSPCGEIH RVTILCDKFS
190 200 210 220 230 240
GHPKGYAYIE FASHRSVKAA VGLDESTFRG RVIKVLPKRT NFPGISSTDR GGLRTHSGNR
250 260 270
AAFLHGSLHR KARLRAHGRS RGHGGAPQWF SPY